Participant safety planning and support network coordination

The manuals converge on the need to identify a reachable support person or emergency contact early, and to coordinate that person’s role around safe discharge, transport, overnight support, and emergency response. Across the extracts, support persons are oriented to their limits, given contact information, and linked to the participant’s post-session safety plan rather than being treated as therapists or interpreters of the experience. They also agree that support persons may need preparation in advance, including meeting or speaking before dosing, clarifying boundaries, and understanding when to call for help. Several sources explicitly connect this coordination to safe arrival home, next-day logistics, and ongoing monitoring after dosing. The main differences are in emphasis and scope. MAPP2 explicitly mentions outside therapists or psychiatrists for complication management, while the other manuals focus more on companions, attendants, caregivers, or family members. The ClinicalTrials.gov protocol places particular weight on caregiver accompaniment and availability for up to 24 hours, whereas the Yale manual and MAPP1 emphasise designated support persons and overnight supervision, and MAPP2 also highlights confidentiality and protocol boundaries in a broader way.